Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lloyd A. Rowland currently holds 130,797 shares of AMYLIN PHARMACEUTICALS INC (AMLN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lloyd A. Rowland has been a net seller of AMLN stock. They have purchased $93.0K and sold $2.7M worth of shares.
Lloyd A. Rowland's most recent insider trade was on Aug 20, 2024, when they sold 11,250 shares at $0.00 per share.
Lloyd A. Rowland serves as Executive at AMYLIN PHARMACEUTICALS INC (AMLN). They have executed 115 insider transactions totaling $2.8M over their tenure at the company.
Lloyd A. Rowland holds the position of Executive at AMYLIN PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Lloyd A. Rowland has shown a selling trading pattern, with $93.0K in total purchases and $2.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Lloyd A. Rowland was on Aug 8, 2012, when they sold $1.1M worth of AMLN shares. This transaction involved 35,014.2 shares at $31.00 per share.
Lloyd A. Rowland currently owns 130,797 shares of AMYLIN PHARMACEUTICALS INC (AMLN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lloyd A. Rowland's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lloyd A. Rowland has 115 Form 4 filings on record as an insider at AMYLIN PHARMACEUTICALS INC.
Set alerts for Lloyd A. Rowland and 40,000+ other insiders.